Cuu Long Pharmaceutical JSC
VN:DCL
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| VN |
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
4.2T VND |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
996.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.9B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286.8B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.1B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
239.3B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.8B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.8B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.5B USD |
Loading...
|
Market Distribution
| Min | -798.7% |
| 30th Percentile | 9.6% |
| Median | 15.6% |
| 70th Percentile | 28% |
| Max | 206.1% |
Other Profitability Ratios
Cuu Long Pharmaceutical JSC
Glance View
Cuu Long Pharmaceutical JSC engages in the manufacture, sale, import, and export of pharmaceutical, capsules, and medical instruments. The company is headquartered in Vinh Long, Vinh Long and currently employs 934 full-time employees. The company went IPO on 2008-09-17. The firm manufactures, markets and distributes pharmaceutical drugs and capsules, as well as medical equipment and supplies. The company is also involved in the manufacture and trading of functional food, cosmetic products, chemicals and other materials for pharmaceutical production. Other activities include the manufacture of specialized packagings for drugs and medical products, as well as the cultivation of traditional herbs.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Cuu Long Pharmaceutical JSC is 15.4%, which is below its 3-year median of 19.5%.
Over the last 3 years, Cuu Long Pharmaceutical JSC’s Gross Margin has decreased from 29.2% to 15.4%. During this period, it reached a low of 15.4% on Jun 30, 2025 and a high of 29.2% on Jun 30, 2022.
